Immune to Cancer: The CRI Blog
-
CRI-Funded Trial Reveals Promising Potential of Immunotherapy Combination in Metastatic Pancreatic Cancer
Interim data from a novel immunotherapy-chemotherapy combination that targets the CD40 and PD-1 pathways show promising anti-tumor…
-
Personalizing Cancer Treatment
Dr. Patrick Hwu discusses the current state of cancer care and how recent advances are enabling doctors…
-
Transforming Experience into Advocacy
Judy Perkins discusses her experience receiving immunotherapy for metastatic stage 4 breast cancer and insights she shared…
-
AACR19 Preview: CRI Scientists Showcase the Future of Immunotherapy
The 2019 AACR annual meeting kicks off March 29 in Atlanta and will feature the work of…
-
Immunotherapy Combination Approved as First-Line Option for Patients with Advanced Triple-Negative Breast Cancer
Patients with advanced triple-negative breast cancer can now receive frontline treatment with immunotherapy in combination with chemotherapy.
-
Spin to Give to Cancer Research Institute
Laura Geminiana organized a unique birthday fundraiser this year: a spin class where she and members donated…
-
Charles Graeber Follows Glimmers of Light Leading to the Breakthrough Emergence of Cancer Immunotherapy
An interview with bestselling author Charles Graeber about his new book, The Breakthrough: Immunotherapy and the Race…
-
Research, Data, and Healthcare Access for Rare Cancers
Dr. Jill O’Donnell-Tormey participated in an expert panel discussion on rare cancers for The Forum at the…
-
A Golf Tournament Honoring Two Brothers’ Legacy
Trevor Smith honored his father and uncle with the Fourth Annual Jim and Jerry Smith Memorial Golf…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.